Acoramidis Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 356 mg

Reference Brands: Attruby(USA/EU), Beyonttra (UK)

Category: Heart Disorder

Acoramidis is a first-in-class oral transthyretin (TTR) stabilizer designed for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults. This rare and progressive heart condition can lead to heart failure and increased risk of cardiovascular death. Acoramidis works by stabilizing the TTR protein, preventing amyloid deposits in the heart, thereby reducing cardiovascular death and related hospitalizations. Acoramidis is available in Tablet and strengths such as 356 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Acoramidis is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Acoramidis can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.